Clinical trials: Human Metapneumovirus
Healthy
Safety and Immunogenicity of IVX-A12 in Healthy Older Adults
The main purpose of this study is to evaluate the safety and immunogenicity of three dosage levels (low, medium, high) of the bivalent combination respiratory syncytial virus (RSV)/human metapneumovirus (hMPV) virus-like particle…
- Trial name
- NCT05664334
- Testing
- IVX-121, IVX-241, MF59®
- Where
- 4 sites in United States
- Volunteers
- 140 people, healthy volunteers welcome
- Sponsor
- Icosavax, Inc.